HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$7.80
Day range
$7.45 - $7.75
Year range
$2.65 - $13.70
Market cap
468.96M USD
Avg Volume
511.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 29.83M | 158.98% |
Net income | -26.87M | -8.44% |
Net profit margin | — | — |
Earnings per share | -0.43 | -4.88% |
EBITDA | -29.36M | -7.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 213.31M | -28.38% |
Total assets | 232.59M | -27.57% |
Total liabilities | 19.00M | -23.60% |
Total equity | 213.59M | — |
Shares outstanding | 62.15M | — |
Price to book | 2.27 | — |
Return on assets | -30.43% | — |
Return on capital | -31.76% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -26.87M | -8.44% |
Cash from operations | -25.28M | -4.84% |
Cash from investing | 38.13M | 140.59% |
Cash from financing | 1.65M | -98.60% |
Net change in cash | 14.50M | 4,082.14% |
Free cash flow | -19.68M | -26.25% |
About
Founded
2015
Website
Employees
76